Skip to main content
SpringerLink
Log in

Role of Three-Dimensional Echocardiography in Drug Trials

  • Chapter
  • First Online:
Textbook of Real-Time Three Dimensional Echocardiography

  • 1186 Accesses

Abstract

There are two main typologies of clinical trials in whom echocardiography may be used. The first one is represented by studies in which echocardiography is used as part of the assessment, but does not contribute substantially to the end-points. This is the case of trials using echo parameters to define a given study population, a use accepted and supported also by the regulatory authorities. The second one, more ambitious for echocardiography, corresponds to studies involving echocardiographic measurements (e.g., chamber volume and/or shape and LV mass) as primary or secondary efficacy and safety end-points. This second use of echocardiography is debated, at least when the effect of a therapy is concerned. In fact, for phase II trials echo parameters are considered acceptable to prove a concept of a treatment, while the use of echo measures as primary end-points in phase III (purpose of registering a drug) remains controversial. In this case it is necessary to demonstrate that a given echo measure is a real surrogate of clinical events. In this view, the prognostic value alone is not sufficient and should be combined with the demonstration that modifications of the echo measures correspond (better if proportionally) to changes in outcome events. By analyzing the existing notes for guidance of regulatory authorities, echo parameters are not established end-points of pivotal trials designed in order to approve new drugs in conditions like heart failure, post-myocardial infarction dysfunction and arterial hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.

    Article  PubMed  Google Scholar 

  2. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ et al. American Society of Echocardiography. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004;17:1086–1119.

    PubMed  Google Scholar 

  3. Gardner BI, Bingham SE, Allen MR, Blatter DD, Anderson JL. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment of cardiac volumes and regional function after myocardial infarction: an intrasubject comparison using simultaneous intrasubject recordings. Cardiovasc Ultrasound. 2009;7:38.

    Article  PubMed  Google Scholar 

  4. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU et al. Comparison of inter-study reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29–34.

    Article  PubMed  Google Scholar 

  5. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol. 2004;44: 1030–1035.

    Article  PubMed  Google Scholar 

  6. Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, Nihoyannopoulos P. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur Heart J. 2009;10:194–212.

    Google Scholar 

  7. Jenkins C, Bricknell K, Hanekom L, Marwick TH. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol. 2004;44:878–886.

    Article  PubMed  Google Scholar 

  8. Caiani EG, Corsi C, Zamorano J et al. Improved semiautomated quantification of left ventricular volumes and ejection fraction using 3-dimensional echocardiography with a full matrix-array transducer: comparison with magnetic resonance imaging. J Am Soc Echocardiogr. 2005;18:779–788.

    Article  PubMed  Google Scholar 

  9. Jacobs LD, Salgo IS, Goonewardena S et al. Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data. Eur Heart J. 2006;27:460–468.

    Article  PubMed  Google Scholar 

  10. Mor-Avi V, Jenkins C, Kühl HP, Nesser HJ, Marwick T, Franke A et al. Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error. JACC Cardiovasc Imaging. 2008;1:413–423.

    Article  PubMed  Google Scholar 

  11. Muraru D, Badano L, Piccoli G, Gianfagna P, Del Mestre L, Ermacora D et al. Validation of a novel automated border-detection algorithm for rapid and accurate quantitation of left ventricular volumes based on three-dimensional echocardiography. Eur J Echocardiogr. 2010;11(4):359–368.

    Google Scholar 

  12. Gottdiener JS, Livengood SV, Meyer PS, Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol. 1995;25:424–430.

    Article  CAS  PubMed  Google Scholar 

  13. de Simone G, Muiesan ML, Ganau A, Longhini C, Verdecchia P, Palmieri V et al. Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. J Hypertens. 1999;17(12 Pt 2):1955–1963.

    Article  CAS  PubMed  Google Scholar 

  14. Palmieri V, Dahlöf B, De Quattro V, Sharpe N, Bella JN, de Simone G et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol. 1999;34:1625–1632.

    Article  CAS  PubMed  Google Scholar 

  15. Mor-Avi V, Sugeng L, Weinert L, MacEneaney P, Caiani EG, Koch R et al. Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation. 2004;110:1814–1818.

    Article  PubMed  Google Scholar 

  16. Caiani EG, Corsi C, Sugeng L, MacEneaney P, Weinert L, Mor-Avi V et al. Improved quantification of left ventricular mass based on endocardial and epicardial surface detection with real time three dimensional echocardiography. Heart. 2006;92:213–219.

    Article  CAS  PubMed  Google Scholar 

  17. van den Bosch AE, Robbers-Visser D, Krenning BJ, McGhie JS, Helbing WA, Meijboom FJ et al. Comparison of real-time three-dimensional echocardiography to magnetic resonance imaging for assessment of left ventricular mass. Am J Cardiol. 2006;97: 113–117.

    Article  PubMed  Google Scholar 

  18. Himelman RB, Cassidy MM, Landzberg JS, Schiller NB. Reproducibility of quantitative two-dimensional echocardiography. Am Heart J. 1988;115:425–431.

    Article  CAS  PubMed  Google Scholar 

  19. Carlsson M, Ugander M, Mosén H, Buhre T, Arheden H. Atrioventricular plane displacement is the major contributor to left ventricular pumping in healthy adults, athletes, and patients with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2007;292:H1452–H1459.

    Article  CAS  PubMed  Google Scholar 

  20. Zacà V, Ballo P, Galderisi M, Mondillo S. Echocardiography in the assessment of left ventricular longitudinal systolic function: current methodology and clinical applications. Heart Fail Rev. 2010;23:37.

    Google Scholar 

  21. Innelli P, Sanchez R, Marra F, Esposito R, Galderisi M. The impact of aging on left ventricular longitudinal function in healthy subjects: a pulsed tissue Doppler study. Eur J Echocardiogr. 2008;9:241–249.

    PubMed  Google Scholar 

  22. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al. American Heart Association writing group on myocardial segmentation and registration for cardiac imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol. 2002;9:240–245.

    Article  PubMed  Google Scholar 

  23. Choi JO, Cho SW, Song YB, Cho SJ, Song BG, Lee SC et al. Longitudinal 2D strain at rest predicts the presence of left main and three vessel coronary artery disease in patients without regional wall motion abnormality. Eur J Echocardiogr. 2009;10:695–701.

    Article  PubMed  Google Scholar 

  24. Mor-Avi V, Jenkins C, Kühl HP, Nesser HJ, Marwick T, Franke A et al. Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error. JACC Cardiovasc Imaging. 2008;1:413–423.

    Article  PubMed  Google Scholar 

  25. Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers. J Am Soc Echocardiogr. 2009;22:776–792.

    Article  PubMed  Google Scholar 

  26. Ghio S, Recusani F, Klersy C, Sebastiani R, Laudisa ML, Campana C et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 2000;85:837–842.

    Article  CAS  PubMed  Google Scholar 

  27. Tamborini G, Muratori M, Brusoni D, Celeste F, Maffessanti F, Caiani EG et al. Is right ventricular systolic function reduced after cardiac surgery? A two- and three-dimensional echocardiographic study. Eur J Echocardiogr. 2009;10:630–634.

    Article  PubMed  Google Scholar 

  28. Meluzín J, Spinarová L, Bakala J, Toman J, Krejcí J, Hude P et al. Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion; a new, rapid, and non-invasive method of evaluating right ventricular systolic function. Eur Heart J. 2001;22: 340–348.

    Article  PubMed  Google Scholar 

  29. Innelli P, Esposito R, Olibet M, Nistri S, Galderisi M. The impact of ageing on right ventricular longitudinal function in healthy subjects: a pulsed tissue Doppler study. Eur J Echocardiogr. 2009;10: 491–498.

    Article  PubMed  Google Scholar 

  30. Meluzín J, Spinarová L, Dusek L, Toman J, Hude P, Krejcí J. Prognostic importance of the right ventricular function assessed by Doppler tissue imaging. Eur J Echocardiogr. 2003;4:262–271.

    Article  PubMed  Google Scholar 

  31. Niemann PS, Pinho L, Balbach T, Galuschky C, Blankenhagen M, Silberbach M et al. Anatomically oriented right ventricular volume measurements with dynamic three-dimensional echocardiography validated by 3-Tesla magnetic resonance imaging. J Am Coll Cardiol. 2007;50:1668–1676.

    Article  PubMed  Google Scholar 

  32. Lu X, Nadvoretskiy V, Bu L, Stolpen A, Ayres N, Pignatelli RH et al. Accuracy and reproducibility of real-time three-dimensional echocardiography for assessment of right ventricular volumes and ejection fraction in children. J Am Soc Echocardiogr. 2008;21:84–89.

    Article  PubMed  Google Scholar 

  33. Maddukuri PV, Vieira ML, De Castro S, Maron MS, Kuvin JT, Patel AR et al. What is the best approach for the assessment of left atrial size? Comparison of various uni-dimensional and two-dimensional parameters with three-dimensional echocardiographically determined left atrial volume. J Am Soc Echocardiogr. 2006;19: 1026–1032.

    Article  PubMed  Google Scholar 

  34. Jenkins C, Bricknell K, Marwick TH. Use of real-time three-dimensional echocardiography to measure left atrial volume: comparison with other echocardiographic techniques. J Am Soc Echocardiogr. 2005;18:991–997.

    Article  PubMed  Google Scholar 

  35. Keller AM, Gopal AS, King DL. Left and right atrial volume by freehand three-dimensional echocardiography: in vivo validation using magnetic resonance imaging. Eur J Echocardiogr. 2000;1: 55–65.

    Article  CAS  PubMed  Google Scholar 

  36. Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999;84:829–832.

    Article  CAS  PubMed  Google Scholar 

  37. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol. 2006;47:1018–1023.

    Article  PubMed  Google Scholar 

  38. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165–193.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Non Invasive Cardiology Department, Dell’Angelo Hospital, Venice, Italy

    Fausto Rigo

Authors
  1. Fausto Rigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maurizio Galderisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Denisa Muraru
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luigi P. Badano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fausto Rigo .

Editor information

Editors and Affiliations

  1. Santa Maria della Misericordia, Istituto di Cardiologia, Azienda Ospedaliera, P.le S. Maria della Misericordia 15, Udine, 33100, Italy

    Luigi Badano

  2. Dept. Medicine, Noninvasive Cardiac Imaging Laboratory, University of Chicago, S. Maryland Ave. 5841, Chicago, 60637, Illinois, USA

    Roberto M. Lang

  3. Instituto Cardiovascular, Hospital Clinico San Carlos, C/Professor Martin Lagos s/n, Madrid, 28040, Spain

    Jose Luis Zamorano

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer London

About this chapter

Cite this chapter

Rigo, F., Galderisi, M., Muraru, D., Badano, L.P. (2010). Role of Three-Dimensional Echocardiography in Drug Trials. In: Badano, L., Lang, R., Zamorano, J. (eds) Textbook of Real-Time Three Dimensional Echocardiography. Springer, London. https://doi.org/10.1007/978-1-84996-495-1_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-495-1_18

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-494-4

  • Online ISBN: 978-1-84996-495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation